CNO Financial Group filings document the insurance holding company's operating results, governance and capital actions. Form 8-K reports furnish quarterly financial results, financial supplements and operating presentations covering life and health insurance, annuities, distribution activity, investment results and capital management.
Proxy and governance filings address annual meeting voting items, director elections, board committee matters, executive compensation and director compensation. Other material-event reports disclose dividend declarations, board appointments or retirements, Regulation FD presentations and securities identified in the company's capital structure.
Maurer Daniel R reported acquisition or exercise transactions in this Form 4 filing.
CNO Financial Group director Daniel R. Maurer reported new equity compensation and updated holdings. He received an award of 6,043 shares of Common Stock as immediately vesting restricted stock units under the CNO Financial Group, Inc. Amended and Restated Long-Term Incentive Plan at a value of $46.17 per share. Following this grant, he directly holds 108,102 shares. A separate entry shows 24,624 shares of Common Stock held indirectly through the Daniel R. Maurer Revocable Trust, reflecting indirect ownership rather than a new market transaction.
CNO Financial Group, Inc. director Ragavan Chetlur S received an equity award in the form of common stock. On May 12, 2026, he was granted 3,574 shares of common stock at a reference price of $46.17 per share, classified as a grant or award acquisition.
The footnote explains this was an award of immediately vesting restricted stock units granted under the company’s Amended and Restated Long-Term Incentive Plan. Following this award, his directly held common stock position increased to 33,325 shares, reflecting routine, compensation-related equity rather than an open‑market purchase.
CNO Financial Group director Steven E. Shebik received an equity award of 3,574 shares of common stock as compensation. The award is described as immediately vesting restricted stock units granted under the CNO Financial Group, Inc. Amended and Restated Long-Term Incentive Plan.
After this grant, Shebik directly holds 56,756 shares of CNO common stock. The filing classifies the transaction as a grant or award acquisition, not an open-market purchase or sale, making this a routine compensation-related update to his equity position.
Turner Jessica A reported acquisition or exercise transactions in this Form 4 filing.
CNO Financial Group director Jessica A. Turner received a grant of 3,574 shares of Common Stock as equity compensation. The award consists of immediately vesting restricted stock units granted under the CNO Financial Group, Inc. Amended and Restated Long-Term Incentive Plan. Following this grant, Turner directly holds 10,584 shares of CNO common stock.
Gibson Linda T. reported acquisition or exercise transactions in this Form 4 filing.
CNO Financial Group, Inc. director Linda T. Gibson reported an equity award of 3,574 shares of common stock on May 12, 2026. The award was valued at $46.17 per share and was granted as immediately vesting restricted stock units under the company’s Amended and Restated Long-Term Incentive Plan.
Following this grant, Gibson’s indirect holdings through the Linda T. Gibson Revocable Trust Agreement increased to 4,817 shares of CNO common stock. This is a compensation-related award rather than an open‑market share purchase or sale.
CNO Financial Group, Inc. filed a Form 13F reporting its institutional holdings as of the reporting period. The filing lists 18 holdings with a total market value of $174,426,642 and names 40/86 Advisors, Inc. as an other included manager. The report was signed by Joel T. Koehneman on 05-13-2026.
CNO Financial Group, Inc. reported that Karen J. DeToro, President of its Worksite Division, made a bona fide gift of 4,400 shares of Common Stock as a charitable donation. The gift carried no sale price, and she now directly holds 46,124 shares following the transaction.
CNO Financial Group, Inc. reports first-quarter 2026 results with net income of $37.7 million, up from $21.5 million a year earlier. Total revenues rose slightly to $1,029.6 million from $1,004.1 million, as insurance policy income and net investment income both increased.
Basic earnings per share grew to $0.40 from $0.21, while diluted EPS was $0.39. Comprehensive results were pressured by investment markets, as other comprehensive loss of $102.6 million turned total comprehensive income to a loss of $64.9 million. Operating cash flow improved to $148.8 million, and cash and cash equivalents ended at $1,154.3 million. Shareholders’ equity declined to $2,498.4 million, reflecting higher accumulated other comprehensive loss and share repurchases.
CNO Financial Group reported solid first quarter 2026 results, highlighting growth in earnings and sales. Net income was $37.7 million, or $0.39 per diluted share, while net operating income rose to $101.3 million, or $1.05 per diluted share, up 33% from a year earlier.
Revenue reached $1,029.6 million and income from insurance products grew, supported by strong annuity, health and life margins. Total new annualized premiums increased 11% and Medicare policies sold rose 24%, reflecting sustained sales momentum. Book value per share was $26.64, or $38.98 excluding accumulated other comprehensive loss. Operating return on equity excluding significant items was 12.2%, and the statutory risk-based capital ratio was about 375%. CNO repurchased $60.0 million of stock, or 1.4 million shares at an average price of $41.79, and paid $17.1 million in common dividends.
Vanguard Capital Management reports beneficial ownership of 4,825,453 shares of CNO Financial Group Inc, representing 5.14% of the class as of 03/31/2026. The filing states Vanguard has sole voting power for 720,971 shares and sole dispositive power for 4,825,453 shares. The disclosure cites affiliated Vanguard entities and notes no single outside person holds more than 5% of the class. The form is signed on 04/29/2026.